Major Bismuth Subsalicylate Tablet, Chewable
Product Images NDC 68788-8239

1 FDA label image from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Major Bismuth Subsalicylate (NDC 68788-8239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bismuth Subsalicylate Tablets 262mg (122 Maj)

Bismuth Subsalicylate Tablets 262mg (122 Maj)
Major Bismuth Subsalicylate 262 mg chewable tablets label with active ingredient Bismuth subsalicylate 262 mg. The label includes dosage form as tablets, manufacturer Major Pharm., Livonia, MI, and contains warnings about allergy and use. Directions for use are partially visible in English and Spanish with blank spaces for dosing instructions. Barcode and lot information sections are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.